L. Townsend

发表

COVID19 coagulopathy in Caucasian patients

N. O'Connell, I. Martín-Loeches, C. Bergin, 2020, British journal of haematology.

Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection

J. Dowds, J. Dunne, I. Martín-Loeches, 2020, medRxiv.

Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection

J. Dowds, R. Kenny, P. McCluskey, 2021, Nutrients.

Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation

B. Schwikowski, S. Shorte, F. Rieux-Laucat, 2022, Cell Reports.

Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation

I. Martín-Loeches, P. Mallon, G. Curley, 2020, British journal of haematology.

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

T. Renné, I. Martín-Loeches, D. McGonagle, 2021, Journal of Thrombosis and Haemostasis.

Sustained VWF‐ADAMTS‐13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction

J. Dunne, R. Kiersey, I. Martín-Loeches, 2022, Journal of Thrombosis and Haemostasis.

1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study

J. Dowds, I. Martín-Loeches, B. Kent, 2022, Respiratory Research.

Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin

C. Merry, E. Relihan, C. Bergin, 2020, British journal of clinical pharmacology.

A Peculiar Case of Invasive Streptococcus pneumoniae

A. Ahmed, C. Fleming, H. Tuite, 2017, Case reports in infectious diseases.

Neuropsychological decrements in midlife type-2 diabetes are not associated with peripheral NLRP3 inflammasome responsiveness

J. Gibney, S. Kennelly, D. O'Neill, 2022, Frontiers in Immunology.

More on COVID‐19 coagulopathy in Caucasian patients

N. O'Connell, I. Martín-Loeches, C. Bergin, 2020, British journal of haematology.

Invasive Aspergillosis in the Intensive Care Unit

I. Martín-Loeches, L. Townsend, 2022, Diagnostics.

Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection

C. Bergin, G. Hughes, R. O'Connor, 2020, JAC-antimicrobial resistance.

Reply: The Impact of Acute Illness Severity on Post–COVID-19 Sequelae Remains an Unsettled Question

J. Dowds, I. Martín-Loeches, L. Townsend, 2021, Annals of the American Thoracic Society.

Studying severe long COVID to understand post-infectious disorders beyond COVID-19

Mark S. Anderson, P. Gregersen, J. Casanova, 2022, Nature Medicine.

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection

A. Meola, A. Fontanet, B. Hoen, 2021, The Journal of infectious diseases.

Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteins

A. Meola, A. Fontanet, B. Hoen, 2021, medRxiv.

Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study

Thomas A. Jackson, C. Steves, G. Sammarco, 2021, Age and ageing.

Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response

I. Martín-Loeches, C. Bergin, N. Conlon, 2021, Journal of Thrombosis and Haemostasis.

Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression

J. Dunne, R. Kiersey, D. Byrne, 2021, Heliyon.

Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health

J. Dowds, P. Fallon, J. Dunne, 2020, Frontiers in Immunology.

Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity

J. Dowds, J. Dunne, I. Martín-Loeches, 2021, Annals of the American Thoracic Society.

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Inge Christoffer Olsen, F. Lund-Johansen, Mariana H. S. Bernardo, 2023, Critical Care.

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity

J. Casanova, D. Duffy, O. Schwartz, 2022, Nature Communications.

Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets

S. Savinelli, L. Townsend, G. Kenny, 2023, Frontiers in Molecular Biosciences.

More on Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity.

J. Dowds, I. Martín-Loeches, L. Townsend, 2021, Annals of the American Thoracic Society.

Fatigue following COVID-19 infection is not associated with autonomic dysfunction

R. Kenny, C. Finucane, C. Bergin, 2021, PloS one.

Study protocol for the St James's Hospital, Tallaght University Hospital, Trinity College Dublin Allied Researchers' (STTAR) Bioresource for COVID-19

R. McManus, R. Romero-Ortuño, P. Fallon, 2022, HRB open research.

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

A changing demographic – Ten years of HIV care

C. Bergin, C. Kerr, L. Townsend, 2021, International journal of STD & AIDS.

Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation

B. Schwikowski, S. Shorte, F. Rieux-Laucat, 2022, Cell Reports.

Immune response in vaccinated healthcare workers with frequent COVID-19 infections is characterised by blunted IFNγ and IL-2 responses to SARS-CoV-2 variants.

L. Townsend, Cian Reid, Colm Bergin, 2024, Clinical immunology.